Author Correction: Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury (Nature, (2019), 565, 7737, (96-100), 10.1038/s41586-018-0749-z);Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury

Nature

Volumn 565, Issue 7737, 2019, Pages 96-100

  Zhou, Hua Lin ^a   Zhang, Rongli ^a   Anand, Puneet ^a   Stomberski, Colin T ^a   Qian, Zhaoxia ^a   Hausladen, Alfred ^a   Wang, Liwen ^a   Rhee, Eugene P ^b,c   Parikh, Samir M ^d   Karumanchi, S Ananth ^d,e   Stamler, Jonathan S ^a,f  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITROSO CO ENZYME A REDUCTASE; OXIDOREDUCTASE; PENTOSE PHOSPHATE; PYRUVATE KINASE; PYRUVATE KINASE M2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AKR1A1 PROTEIN, MOUSE; ALDEHYDE REDUCTASE; COENZYME A; S-NITROSO-COENZYME A;

ACUTE KIDNEY FAILURE; AKR1A1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENOS GENE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME METABOLISM; FEMALE; GENE; GENE DELETION; GLYCOLYSIS; KIDNEY METABOLISM; KIDNEY PROXIMAL TUBULE; LETTER; LIPID PEROXIDATION; MALE; METABOLIC REGULATION; METABOLIC REPROGRAMMING; METABOLISM; MOUSE; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RENAL PROTECTION; SURVIVAL; TISSUE DIFFERENTIATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DEFICIENCY; ENZYMOLOGY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLIC ENGINEERING; MUTATION; PROTEIN MULTIMERIZATION;

MAMMALIA; MUS; SACCHAROMYCES CEREVISIAE;

ACUTE KIDNEY INJURY; ALDEHYDE REDUCTASE; ANIMALS; CELL LINE; COENZYME A; FEMALE; GLYCOLYSIS; HEK293 CELLS; HUMANS; KIDNEY TUBULES, PROXIMAL; MALE; METABOLIC ENGINEERING; MICE; MUTATION; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; OXIDOREDUCTASES; PENTOSE PHOSPHATE PATHWAY; PROTEIN MULTIMERIZATION; PYRUVATE KINASE;

EID: 85058911853     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-019-1225-0     Document Type: Erratum

References (42)

1. Wang, W. et al. Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am. J. Physiol. Renal Physiol. 287, F1044–F1048 (2004)
2. Forbes, M. S., Thornhill, B. A., Park, M. H. & Chevalier, R. L. Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. Am. J. Pathol. 170, 87–99 (2007)
3. Seth, D. et al. A multiplex enzymatic machinery for cellular protein S-nitrosylation. Mol. Cell 69, 451–464 (2018)
4. Stomberski, C. T., Hess, D. T. & Stamler, J. S. Protein S-nitrosylation: determinants of specificity and enzymatic regulation of S-nitrosothiol-based signaling. Antioxid. Redox Signal. 10.1089/ars.2017.7403 (2018)
5. Anand, P. et al. Identification of S-nitroso-CoA reductases that regulate protein S-nitrosylation. Proc. Natl Acad. Sci. USA 111, 18572–18577 (2014)
6. Nagasu, H. et al. Endothelial dysfunction promotes the transition from compensatory renal hypertrophy to kidney injury after unilateral nephrectomy in mice. Am. J. Physiol. Renal Physiol. 302, F1402–F1408 (2012)
7. Gabbay, K. H. et al. Ascorbate synthesis pathway: dual role of ascorbate in bone homeostasis. J. Biol. Chem. 285, 19510–19520 (2010)
8. Jia, J. et al. Target-selective protein S-nitrosylation by sequence motif recognition. Cell 159, 623–634 (2014)
9. Lan, R. et al. Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI. J. Am. Soc. Nephrol. 27, 3356–3367 (2016)
10. Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37–46 (2015)
11. Chang, G. G. & Tong, L. Structure and function of malic enzymes, a new class of oxidative decarboxylases. Biochemistry 42, 12721–12733 (2003)
12. Gray, L. R., Tompkins, S. C. & Taylor, E. B. Regulation of pyruvate metabolism and human disease. Cell. Mol. Life Sci. 71, 2577–2604 (2014)
13. Anastasiou, D. et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278–1283 (2011)
14. Qi, W. et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat. Med. 23, 753–762 (2017)
15. Fan, J. et al. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510, 298–302 (2014)
16. +-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am. J. Physiol. Renal Physiol. 296, F622–F633 (2009)
17. Sharfuddin, A. A. & Molitoris, B. A. Pathophysiology of ischemic acute kidney injury. Nat. Rev. Nephrol. 7, 189–200 (2011)
18. Granger, D. N. & Kvietys, P. R. Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 6, 524–551 (2015)
19. Zuk, A. & Bonventre, J. V. Acute kidney injury. Annu. Rev. Med. 67, 293–307 (2016)
20. Ratliff, B. B., Abdulmahdi, W., Pawar, R. & Wolin, M. S. Oxidant mechanisms in renal injury and disease. Antioxid. Redox Signal. 25, 119–146 (2016)
21. Benavides, G. A., Liang, Q., Dodson, M., Darley-Usmar, V. & Zhang, J. Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons. Free Radic. Biol. Med. 65, 1215–1228 (2013)
22. Almeida, A., Moncada, S. & Bolaños, J. P. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat. Cell Biol. 6, 45–51 (2004)
23. Bolaños, J. P., Delgado-Esteban, M., Herrero-Mendez, A., Fernandez-Fernandez, S. & Almeida, A. Regulation of glycolysis and pentose-phosphate pathway by nitric oxide: impact on neuronal survival. Biochim. Biophys. Acta 1777, 789–793 (2008)
24. O’Connor, T., Ireland, L. S., Harrison, D. J. & Hayes, J. D. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 343, 487–504 (1999)
25. Alzeer, S. & Ellis, E. M. The role of aldehyde reductase AKR1A1 in the metabolism of γ-hydroxybutyrate in 1321N1 human astrocytoma cells. Chem. Biol. Interact. 191, 303–307 (2011)
26. Barski, O. A., Tipparaju, S. M. & Bhatnagar, A. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab. Rev. 40, 553–624 (2008)
27. Doulias, P. T., Tenopoulou, M., Greene, J. L., Raju, K. & Ischiropoulos, H. Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci. Signal. 6, rs1 (2013)
28. Anastasiou, D. et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8, 839–847 (2012)
29. Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230–233 (2008)
30. Ye, J. et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc. Natl Acad. Sci. USA 109, 6904–6909 (2012)
31. Israelsen, W. J. et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155, 397–409 (2013)
32. Shao, X., Somlo, S. & Igarashi, P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J. Am. Soc. Nephrol. 13, 1837–1846 (2002)
33. Tran, M. T. et al. PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531, 528–532 (2016)
34. Forrester, M. T. et al. Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat. Biotechnol. 27, 557–559 (2009)
35. Zhou, H. L., Geng, C., Luo, G. & Lou, H. The p97–UBXD8 complex destabilizes mRNA by promoting release of ubiquitinated HuR from mRNP. Genes Dev. 27, 1046–1058 (2013)
36. Stamler, J. S. et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl Acad. Sci. USA 89, 7674–7677 (1992)
37. Solez, K., Morel-Maroger, L. & Sraer, J. D. The morphology of “acute tubular necrosis” in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 58, 362–376 (1979)
38. Conger, J. D., Schultz, M. F., Miller, F. & Robinette, J. B. Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int. 46, 318–323 (1994)
39. Fujioka, H., Tandler, B. & Hoppel, C. L. Mitochondrial division in rat cardiomyocytes: an electron microscope study. Anat. Rec. (Hoboken) 295, 1455–1461 (2012)
40. Hanaichi, T. et al. A stable lead by modification of Sato’s method. J. Electron Microsc. (Tokyo) 35, 304–306 (1986)
41. Hitosugi, T. et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2, ra73 (2009)
42. Paynter, N. P. et al. Metabolic predictors of incident coronary heart disease in women. Circulation 137, 841–853 (2018)